146 related articles for article (PubMed ID: 32974761)
1. Effect of sarcopenia on systemic targeted therapy response in patients with advanced hepatocellular carcinoma.
Qayyum A; Bhosale P; Aslam R; Avritscher R; Ma J; Pagel MD; Sun J; Mohamed Y; Rashid A; Beretta L; Kaseb AO
Abdom Radiol (NY); 2021 Mar; 46(3):1008-1015. PubMed ID: 32974761
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenia Impairs Prognosis of Patients with Hepatocellular Carcinoma: The Role of Liver Functional Reserve and Tumor-Related Factors in Loss of Skeletal Muscle Volume.
Imai K; Takai K; Watanabe S; Hanai T; Suetsugu A; Shiraki M; Shimizu M
Nutrients; 2017 Sep; 9(10):. PubMed ID: 28937616
[TBL] [Abstract][Full Text] [Related]
3. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
[TBL] [Abstract][Full Text] [Related]
4. Adverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resection.
Yabusaki N; Fujii T; Yamada S; Suzuki K; Sugimoto H; Kanda M; Nakayama G; Koike M; Fujiwara M; Kodera Y
Int J Surg; 2016 Jun; 30():136-42. PubMed ID: 27154615
[TBL] [Abstract][Full Text] [Related]
5. Progressive sarcopenia and myosteatosis predict prognosis of advanced HCC patients treated with immune checkpoint inhibitors.
Liu M; Jin Q; Wang H; Li Y
Front Immunol; 2024; 15():1396927. PubMed ID: 38690276
[TBL] [Abstract][Full Text] [Related]
6. Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma.
Lanza E; Masetti C; Messana G; Muglia R; Pugliese N; Ceriani R; Lleo de Nalda A; Rimassa L; Torzilli G; Poretti D; D'Antuono F; Politi LS; Pedicini V; Aghemo A;
PLoS One; 2020; 15(6):e0232371. PubMed ID: 32555707
[TBL] [Abstract][Full Text] [Related]
7. Assessment of muscle mass using chest computed tomography-based quantitative and qualitative measurements in patients with systemic sclerosis: A retrospective study with cross-sectional and longitudinal analyses.
da Rocha DS; Tessari JA; Mainardi NB; Hax V; Gasparin AA; de Oliveira CAV; Garcia TS; Xavier RM; Chakr RMDS
Semin Arthritis Rheum; 2023 Apr; 59():152168. PubMed ID: 36736023
[TBL] [Abstract][Full Text] [Related]
8. Sarcopenia predicts reduced survival in patients with hepatocellular carcinoma at first diagnosis.
Begini P; Gigante E; Antonelli G; Carbonetti F; Iannicelli E; Anania G; Imperatrice B; Pellicelli AM; Fave GD; Marignani M
Ann Hepatol; 2017 Jan-Feb 2017; 16(1):107-114. PubMed ID: 28051799
[TBL] [Abstract][Full Text] [Related]
9. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.
Iritani S; Imai K; Takai K; Hanai T; Ideta T; Miyazaki T; Suetsugu A; Shiraki M; Shimizu M; Moriwaki H
J Gastroenterol; 2015 Mar; 50(3):323-32. PubMed ID: 24817668
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous Fat Thickness of the Lower Limb is Associated with Trunk Muscle Mass in Patients with Hepatocellular Carcinoma: A Simple Assessment for Sarcopenia Using Conventional Ultrasonography.
Sakai M; Kawaguchi T; Koya S; Hirota K; Matsuse H; Torimura T
Kurume Med J; 2022 Nov; 67(2.3):97-105. PubMed ID: 36130884
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy.
Yang H; Cong T; Luo Y; Yang C; Ren J; Li X
J Hepatocell Carcinoma; 2024; 11():175-189. PubMed ID: 38283695
[TBL] [Abstract][Full Text] [Related]
12. "Sarcopenia and intramuscular fat deposition are associated with poor survival in Indonesian patients with hepatocellular carcinoma: a retrospective study".
Mardian Y; Yano Y; Ratnasari N; Choridah L; Wasityastuti W; Setyawan NH; Hayashi Y
BMC Gastroenterol; 2019 Dec; 19(1):229. PubMed ID: 31888500
[TBL] [Abstract][Full Text] [Related]
13. Transversal psoas muscle thickness measurement is associated with response and survival in patients with HCC undergoing immunotherapy.
Scheiner B; Lampichler K; Pomej K; Beer L; Balcar L; Sartoris R; Bouattour M; Sidali S; Trauner M; Mandorfer M; Reiberger T; Scharitzer M; Tamandl D; Pinato DJ; Ronot M; Pinter M
Hepatol Commun; 2023 Oct; 7(10):. PubMed ID: 37708441
[TBL] [Abstract][Full Text] [Related]
14. Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: Analysis adjusted with inverse probability weighting.
Hiraoka A; Kumada T; Kariyama K; Tada T; Tani J; Fukunishi S; Atsukawa M; Hirooka M; Tsuji K; Ishikawa T; Takaguchi K; Itobayashi E; Tajiri K; Shimada N; Shibata H; Ochi H; Kawata K; Yasuda S; Toyoda H; Ohama H; Nouso K; Tsutsui A; Nagano T; Itokawa N; Hayama K; Arai T; Imai M; Koizumi Y; Nakamura S; Joko K; Michitaka K; Hiasa Y; Kudo M;
J Gastroenterol Hepatol; 2021 Jul; 36(7):1812-1819. PubMed ID: 33171524
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of Sarcopenia Using the L3 Skeletal Muscle Index Estimated From the L1 Skeletal Muscle Index on MR Images in Patients With Cirrhosis.
Xu Z; Yang D; Luo J; Xu H; Jia J; Yang Z
J Magn Reson Imaging; 2023 Nov; 58(5):1569-1578. PubMed ID: 36932680
[TBL] [Abstract][Full Text] [Related]
16. Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody.
Akce M; Liu Y; Zakka K; Martini DJ; Draper A; Alese OB; Shaib WL; Wu C; Wedd JP; Sellers MT; Bilen MA; El-Rayes BF
Am J Clin Oncol; 2021 Feb; 44(2):74-81. PubMed ID: 33350681
[TBL] [Abstract][Full Text] [Related]
17. Total skeletal, psoas and rectus abdominis muscle mass as prognostic factors for patients with advanced hepatocellular carcinoma.
Wu CH; Liang PC; Hsu CH; Chang FT; Shao YY; Ting-Fang Shih T
J Formos Med Assoc; 2021 Jan; 120(1 Pt 2):559-566. PubMed ID: 32651043
[TBL] [Abstract][Full Text] [Related]
18. Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma.
Chen BB; Liang PC; Shih TT; Liu TH; Shen YC; Lu LC; Lin ZZ; Hsu C; Hsu CH; Cheng AL; Shao YY
Eur Radiol; 2023 Jan; 33(1):512-522. PubMed ID: 35864351
[TBL] [Abstract][Full Text] [Related]
19. The role of muscle depletion and visceral adiposity in HCC patients aged 65 and over undergoing TACE.
Lim J; Kim KW; Ko Y; Jang IY; Lee YS; Chung YH; Lee HC; Lim YS; Kim KM; Shim JH; Choi J; Lee D
BMC Cancer; 2021 Oct; 21(1):1164. PubMed ID: 34715813
[TBL] [Abstract][Full Text] [Related]
20. Sarcopenia Predicts Prognosis in Patients with Newly Diagnosed Hepatocellular Carcinoma, Independent of Tumor Stage and Liver Function.
Ha Y; Kim D; Han S; Chon YE; Lee YB; Kim MN; Lee JH; Park H; Rim KS; Hwang SG
Cancer Res Treat; 2018 Jul; 50(3):843-851. PubMed ID: 28882021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
